IMV Inc. (IMV) - 5i Research

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

Q: Hi Team, IMV 3rd quarter 2020 results and clinical update is good ?and worth to gamble on this company ?
Thanks as always,
Tak

Read Answer Asked by Tak on November 16, 2020

IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV

Q: Is there a potentially worthwhile option in the Canadian market for a company that's working on a vaccine, even indirectly?

Read Answer Asked by Bashir on August 05, 2020

Regeneron Pharmaceuticals Inc. (REGN $753.55)
- $753.55 P/E (TTM): 18.07X Cap: $79.19B
- View REGN Profile
- View Questions on REGN
Pfizer Inc. (PFE $25.65)
- $25.65 P/E (TTM): 15.17X Cap: $145.83B
- View PFE Profile
- View Questions on PFE
IMV Inc. (IMV $1.12)
- View IMV Profile
- View Questions on IMV
Inovio Pharmaceuticals Inc. (INO $1.51)
- $1.51 Cap: $80M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.17)
- $9.17 P/E (TTM): 5.16X Cap: $1.49B
- View NVAX Profile
- View Questions on NVAX
Moderna Inc. (MRNA $48.71)
- $48.71 Cap: $19.02B
- View MRNA Profile
- View Questions on MRNA
BioNTech SE (BNTX $115.98)
- $115.98 Cap: $27.83B
- View BNTX Profile
- View Questions on BNTX

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Read Answer Asked by Brian on July 14, 2020